Cholesterol is a lipid (fat) that is necessary for our bodies to function. Higher than normal levels of cholesterol in the blood can cause damage to blood vessels by accumulating in the vessel and forming plaques that can obstruct or block blood flow and cause narrowing of the blood vessels. High cholesterol (hypercholesterolemia) increases the risk of heart disease and stroke. Other factors that increase risk of heart disease are smoking, high blood pressure, diabetes, being overweight, older age, and having a family member who had a heart attack at a young age. The May 12, 2004, issue of JAMA includes an article about treating high cholesterol levels in women.
High cholesterol itself does not cause any symptoms, so it is important to have your cholesterol level checked. The choice of treatment depends on the level of a person's risk for heart disease in addition to cholesterol level. There are several options for treating high cholesterol that you should discuss with your doctor.
Eating a diet rich in fruits and vegetables, low in saturated fats, and low in total fat content can help to lower cholesterol to healthful levels.
Engaging in regular exercise for at least 30 minutes each day lowers cholesterol levels and prevents type 2 diabetes, lowers risk of heart disease, and reduces or maintains weight. Regular physical activity (such as walking) is a cornerstone of treatment for high cholesterol and related health problems.
Losing excess body weight can lower cholesterol levels. Controlling weight by reducing caloric intake and introducing daily exercise has many beneficial effects, including reducing risk for diabetes, heart attack, and some cancers.
Stopping smoking is important because tobacco products damage blood vessels, making it easier for cholesterol to form plaques.
Medications called statins work in the liver to block production of cholesterol. These medications are effective in reducing cholesterol levels, but the levels go up again if the medicine is stopped. These medicines can have adverse effects that require attention. Liver damage can occur, as well as muscle damage called myopathy. Regular laboratory examinations may be required to check for liver damage. Any muscle pain or weakness that develops while taking a statin medication must be reported immediately to your doctor. Women who are pregnant or nursing should not take statin medications.
Sequestering medications (also called binding agents) combine with bile acids in the intestine. This process makes less cholesterol available to go into the bloodstream.
National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov
American Heart Association 800/242-8721http://www.americanheart.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on cholesterol and atherosclerosis was published in the May 16, 2001, issue; one on cholesterol was published in the January 13, 1999, issue; and one on risk factors for heart disease was published in the August 20, 2003, issue.
Sources: National Heart, Lung, and Blood Institute; American Heart Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.
TOPIC: CARDIOVASCULAR DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.